Register for the hybrid Policy Summit, Sept. 22-24, at the JW Marriott Washington, DC!
Diversity & Inclusion Career Development
Not a member? Anyone with a demonstrated professional interest in gene and cell therapy is invited to join—apply now and earn eligiblity for ASGCT's funded awards.
Join Today!
Supporting six members who are working toward independence in their gene and cell therapy careers. The CDA values have been doubled to $100,000 each in 2021.
ASGCT has created three awards totalling $250,000 as part of the Society's commitment to promoting justice and equity in gene and cell therapy research.
Three awards of up to $20,000 each supporting partnered research between the faculty-level researchers in the United States and countries around the world.
The ASGCT Outstanding Achievement Award recognizes an ASGCT Member who has achieved a pioneering research success, a specific high impact accomplishment, or a lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor.
Several Outstanding New Investigators are recognized each year based on their contributions to the field of gene and cell therapy. Investigators from academia, research foundations, government, and industry are all eligible to be nominated for awards.
Named for its inaugural co-recipient and tireless gene therapy advocate, the Society’s Sonia Skarlatos Public Service Award recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy through governmental agencies, public policy groups, public education, or non-governmental charitable organizations.
Named for the first person to study viral mediated gene therapy for muscular dystrophy in humans, and the principal investigator in the study that led to the FDA approval of Zolgensma to treat SMA, the Jerry Mendell Award for Translational Science recognizes the extensive work required to bring gene and cell therapies to clinical trial. Supported by Dr. Suku and Ann Nagendran
This award highlights the contribution of a lead author under the age of 40 to the Molecular Therapy family of journals.
Each year the ASGCT Abstract Review Committee for the Annual Meeting selects the top six abstracts submitted by students and fellows to receive Excellence in Research Awards.
First introduced in 2016, the ASGCT Underrepresented Minority Travel Awards honor and support ASGCT Associate Members who submitted abstracts to the Annual Meeting.
ASGCT supports the travel of approximately 150 Associate Members each year through the Meritorious Abstract Travel Award program. Recipients will receive a certificate and a travel reimbursement stipend of up to $500 for domestic awardees and $600 for international awardees to the 21st Annual Meeting.
The top poster presentations from each of the three poster sessions that occur during the ASGCT Annual Meeting are awarded Outstanding Poster Presentation Awards.
September 22-24, 2021
© 2000-2021 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico